Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1994 Nov 8;91(23):11236–11240. doi: 10.1073/pnas.91.23.11236

Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene.

I G Maroulakou 1, M Anver 1, L Garrett 1, J E Green 1
PMCID: PMC45202  PMID: 7972041

Abstract

A transgenic mouse model for prostate and mammary cancer has been developed in mice containing a recombinant gene expressing the simian virus 40 early-region transforming sequences under the regulatory control of the rat prostatic steroid binding protein [C3(1)] gene. Male transgenic mice develop prostatic hyperplasia in early life that progresses to adenoma or adenocarcinoma in most animals surviving to longer than 7 months of age. Prostate cancer metastases to lung have been observed. Female animals from the same founder lines generally develop mammary hyperplasia by 3 months of age with subsequent development of mammary adenocarcinoma by 6 months of age in 100% of the animals. The development of tumors correlates with the expression of the transgene as determined by Northern blot and immunohistochemical analyses. The results of these experiments demonstrate that the C3(1) regulatory region used in these experiments is useful for targeting expression to the prostate and mammary gland. To our knowledge, this experimental system is the first reported transgenic mouse model for prostate cancer. These transgenic animals offer the opportunity to study hormone response elements in vivo and the multistage progression from normal tissue to carcinoma in the prostate and mammary glands.

Full text

PDF
11236

Images in this article

11238Image
on p.11238
11239Image
on p.11239
11240Image
on p.11240

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison J., Zhang Y. L., Parker M. G. Tissue-specific and hormonal regulation of the gene for rat prostatic steroid-binding protein in transgenic mice. Mol Cell Biol. 1989 May;9(5):2254–2257. doi: 10.1128/mcb.9.5.2254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Andres A. C., Schönenberger C. A., Groner B., Hennighausen L., LeMeur M., Gerlinger P. Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice. Proc Natl Acad Sci U S A. 1987 Mar;84(5):1299–1303. doi: 10.1073/pnas.84.5.1299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beckman W. C., Jr, Jacokes A. L., Camps J. L., Jr, Cook R. L., Siegal G. P. Analysis of changes in rat prostate carcinoma following hormone deprivation. Am J Pathol. 1987 Sep;128(3):566–572. [PMC free article] [PubMed] [Google Scholar]
  4. Bouchard L., Lamarre L., Tremblay P. J., Jolicoeur P. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell. 1989 Jun 16;57(6):931–936. doi: 10.1016/0092-8674(89)90331-0. [DOI] [PubMed] [Google Scholar]
  5. Buttyan R., Slawin K. Rodent models for targeted oncogenesis of the prostate gland. Cancer Metastasis Rev. 1993 Mar;12(1):11–19. doi: 10.1007/BF00689786. [DOI] [PubMed] [Google Scholar]
  6. Cohen M. B., Heidger P. M., Lubaroff D. M. Gross and microscopic pathology of induced prostatic complex tumors arising in Lobund-Wistar rats. Cancer Res. 1994 Feb 1;54(3):626–628. [PubMed] [Google Scholar]
  7. Greenberg N. M., DeMayo F. J., Sheppard P. C., Barrios R., Lebovitz R., Finegold M., Angelopoulou R., Dodd J. G., Duckworth M. L., Rosen J. M. The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice. Mol Endocrinol. 1994 Feb;8(2):230–239. doi: 10.1210/mend.8.2.8170479. [DOI] [PubMed] [Google Scholar]
  8. Hsu S. M., Soban E. Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry. J Histochem Cytochem. 1982 Oct;30(10):1079–1082. doi: 10.1177/30.10.6182185. [DOI] [PubMed] [Google Scholar]
  9. Hurst H. C., Parker M. G. Rat prostatic steroid binding protein: DNA sequence and transcript maps of the two C3 genes. EMBO J. 1983;2(5):769–774. doi: 10.1002/j.1460-2075.1983.tb01498.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Ito N., Shirai T., Tagawa Y., Nakamura A., Fukushima S. Variation in tumor yield in the prostate and other target organs of the rat in response to varied dosage and duration of administration of 3,2'-dimethyl-4-aminobiphenyl. Cancer Res. 1988 Aug 15;48(16):4629–4632. [PubMed] [Google Scholar]
  11. Jhappan C., Gallahan D., Stahle C., Chu E., Smith G. H., Merlino G., Callahan R. Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev. 1992 Mar;6(3):345–355. doi: 10.1101/gad.6.3.345. [DOI] [PubMed] [Google Scholar]
  12. Jhappan C., Stahle C., Harkins R. N., Fausto N., Smith G. H., Merlino G. T. TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell. 1990 Jun 15;61(6):1137–1146. doi: 10.1016/0092-8674(90)90076-q. [DOI] [PubMed] [Google Scholar]
  13. Leder A., Pattengale P. K., Kuo A., Stewart T. A., Leder P. Consequences of widespread deregulation of the c-myc gene in transgenic mice: multiple neoplasms and normal development. Cell. 1986 May 23;45(4):485–495. doi: 10.1016/0092-8674(86)90280-1. [DOI] [PubMed] [Google Scholar]
  14. Matsui Y., Halter S. A., Holt J. T., Hogan B. L., Coffey R. J. Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Cell. 1990 Jun 15;61(6):1147–1155. doi: 10.1016/0092-8674(90)90077-r. [DOI] [PubMed] [Google Scholar]
  15. Muller W. J., Lee F. S., Dickson C., Peters G., Pattengale P., Leder P. The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J. 1990 Mar;9(3):907–913. doi: 10.1002/j.1460-2075.1990.tb08188.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Muller W. J., Sinn E., Pattengale P. K., Wallace R., Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell. 1988 Jul 1;54(1):105–115. doi: 10.1016/0092-8674(88)90184-5. [DOI] [PubMed] [Google Scholar]
  17. Parker M. G., White R., Hurst H., Needham M., Tilly R. Prostatic steroid-binding protein. Isolation and characterization of C3 genes. J Biol Chem. 1983 Jan 10;258(1):12–15. [PubMed] [Google Scholar]
  18. Pollard M., Luckert P. H. Autochthonous prostate adenocarcinomas in Lobund-Wistar rats: a model system. Prostate. 1987;11(3):219–227. doi: 10.1002/pros.2990110303. [DOI] [PubMed] [Google Scholar]
  19. Pollard M., Luckert P. H., Snyder D. L. The promotional effect of testosterone on induction of prostate-cancer in MNU-sensitized L-W rats. Cancer Lett. 1989 Jun;45(3):209–212. doi: 10.1016/0304-3835(89)90079-7. [DOI] [PubMed] [Google Scholar]
  20. Pollard M., Luckert P. H. Transplantable metastasizing prostate adenocarcinomas in rats. J Natl Cancer Inst. 1975 Mar;54(3):643–649. [PubMed] [Google Scholar]
  21. Sandgren E. P., Luetteke N. C., Palmiter R. D., Brinster R. L., Lee D. C. Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell. 1990 Jun 15;61(6):1121–1135. doi: 10.1016/0092-8674(90)90075-p. [DOI] [PubMed] [Google Scholar]
  22. Shirai T., Tamano S., Kato T., Iwasaki S., Takahashi S., Ito N. Induction of invasive carcinomas in the accessory sex organs other than the ventral prostate of rats given 3,2'-dimethyl-4-aminobiphenyl and testosterone propionate. Cancer Res. 1991 Feb 15;51(4):1264–1269. [PubMed] [Google Scholar]
  23. Sinn E., Muller W., Pattengale P., Tepler I., Wallace R., Leder P. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell. 1987 May 22;49(4):465–475. doi: 10.1016/0092-8674(87)90449-1. [DOI] [PubMed] [Google Scholar]
  24. Stewart T. A., Pattengale P. K., Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell. 1984 Oct;38(3):627–637. doi: 10.1016/0092-8674(84)90257-5. [DOI] [PubMed] [Google Scholar]
  25. Tan J. A., Marschke K. B., Ho K. C., Perry S. T., Wilson E. M., French F. S. Response elements of the androgen-regulated C3 gene. J Biol Chem. 1992 Mar 5;267(7):4456–4466. [PubMed] [Google Scholar]
  26. Thompson T. C., Southgate J., Kitchener G., Land H. Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ. Cell. 1989 Mar 24;56(6):917–930. doi: 10.1016/0092-8674(89)90625-9. [DOI] [PubMed] [Google Scholar]
  27. Tsukamoto A. S., Grosschedl R., Guzman R. C., Parslow T., Varmus H. E. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell. 1988 Nov 18;55(4):619–625. doi: 10.1016/0092-8674(88)90220-6. [DOI] [PubMed] [Google Scholar]
  28. Tzeng Y. J., Guhl E., Graessmann M., Graessmann A. Breast cancer formation in transgenic animals induced by the whey acidic protein SV40 T antigen (WAP-SV-T) hybrid gene. Oncogene. 1993 Jul;8(7):1965–1971. [PubMed] [Google Scholar]
  29. Waalkes M. P., Rehm S., Riggs C. W., Bare R. M., Devor D. E., Poirier L. A., Wenk M. L., Henneman J. R., Balaschak M. S. Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: dose-response analysis of tumor induction in the prostate and testes and at the injection site. Cancer Res. 1988 Aug 15;48(16):4656–4663. [PubMed] [Google Scholar]
  30. Ward J. M., Reznik G., Stinson S. F., Lattuada C. P., Longfellow D. G., Cameron T. P. Histogenesis and morphology of naturally occurring prostatic carcinoma in the ACI/segHapBR rat. Lab Invest. 1980 Dec;43(6):517–522. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES